This is a demo store. No orders will be fulfilled.

Ozoralizumab (anti-TNF-alpha&HSA) - Primary antibody, specific to TNF; ALB, INHIBITOR of TNF-alpha inhibitor, INHIBITOR of TNF-alpha inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Conjugation: Unconjugated
In stock
Item Number
Ab175623
Grouped product items
SKU Size
Availability
Price Qty
Ab175623-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$79.90
Ab175623-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$379.90
Ab175623-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$989.90
Ab175623-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,589.90

Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Ozoralizumab (anti-TNF-alpha&HSA) - Primary antibody, specific to TNF; ALB, INHIBITOR of TNF-alpha inhibitor
Synonyms ATN-103 | APC1 antibody | APC1 protein antibody | Cachectin antibody | DIF antibody | Differentiation inducing factor antibody | Macrophage cytotoxic factor antibody | Tnf antibody | TNF superfamily member 2 antibody | TNF superfamily, member 2 antibody |
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity TNF; ALB
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of TNF-alpha inhibitor
Product Description

Ozoralizumab (anti-TNF-alpha&HSA) is an anti-TNFα humanized antibody. Ozoralizumab (anti-TNF-alpha&HSA) is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab (anti-TNF-alpha&HSA) can be used in research of arthritis.
Purity
≥90% (SDS-PAGE&SEC)
Endotoxin Level
≤1.0EU/mg

Product Properties

SDS-PAGE 38.44 kDa
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1167985-17-2

Associated Targets(Human)

TNF Tclin Tumor necrosis factor (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
ALB Tchem Serum albumin (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
TNF Tclin TNF-alpha (1897 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Ozoralizumab (anti-TNF-alpha&HSA) (Ab175623) - ELISA
Immobilized Recombinant Human TNFα protein at 2.0 μg/mL can bind Ozoralizumab (anti-TNF-alpha&HSA) (Ab175623) with the EC₅₀ of 4.99 ng/mL.

Ozoralizumab (anti-TNF-alpha&HSA) (Ab175623) - SEC
The purity of Ozoralizumab (anti-TNF-alpha&HSA) (Ab175623) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.